Skip to main content
Clinical Trials/DRKS00003681
DRKS00003681
Completed
未知

Transcutaneous Vagus Nerve Stimulation for the treatment of chronic migraine - cMPsCMI01

cerbomed GmbH0 sites46 target enrollmentMarch 23, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
G43.3
Sponsor
cerbomed GmbH
Enrollment
46
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 23, 2012
End Date
November 30, 2014
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
cerbomed GmbH

Eligibility Criteria

Inclusion Criteria

  • males and females from 18 to 70 y. Patients suffering from chronic migraine according to ICHD\-II 1\.5\.1\. Duration of disease of minimum 3 months. Prophylactic medication on a stable regimen for minimum 1 month or 5 half\-lives (the longer duration will be counted). Stable agent(s) for acute medication during baseline period. Patient diary kept properly for minimum 20 out of 28 days, minimum 15 headache days with minimum 4 hours of headache, extrapolation to 28 days.

Exclusion Criteria

  • Participation in another clinical trial during the last 4 weeks before study entry. Pregnant or breastfeeding women. Suffering from craniomandibular dysfunction or fibromyalgia. Other primary/secondary headache disorders (e.g. cluster headache, trigeminal neuralgia, etc.). Beck depression inventory \> 24 at date of inclusion. Other chronic neurological or psychiatric disorders (e.g. psychoses) which impair study participation. Dependance on opioids or benzodiazepines. Anatomical or pathological abnormalities at the left ear. Actual process of retirement.

Outcomes

Primary Outcomes

Not specified

Similar Trials